Woodline Partners’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
ACM
HCM
SCM
MAM
PCM
UOC
TAL
AAM
RSCM
Woodline Partners's AMYT Position: Q1 2023 in Review
Woodline Partners sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 286,543 shares — an estimated $2.09M sold.
Woodline Partners first reported a position in AMYT in Q4 2021 and held it in 5 quarters. The position peaked at $3.97M in Q1 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.
- Woodline Partners reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
- Woodline Partners sold 286,543 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $2.09M.
- Woodline Partners first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2021 and held it in 5 quarters.
- Woodline Partners's Amryt Pharma plc American Depositary Shares position peaked at $3.97M in Q1 2022.
- 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.
Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.